Premium
NMR Chemical Shift Perturbation Study of the N‐Terminal Domain of Hsp90 upon Binding of ADP, AMP‐PNP, Geldanamycin, and Radicicol
Author(s) -
Dehner Alexander,
Furrer Julien,
Richter Klaus,
Schuster Ioana,
Buchner Johannes,
Kessler Horst
Publication year - 2003
Publication title -
chembiochem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.05
H-Index - 126
eISSN - 1439-7633
pISSN - 1439-4227
DOI - 10.1002/cbic.200300658
Subject(s) - geldanamycin , hsp90 , cyclic nucleotide binding domain , binding site , chemistry , biophysics , stereochemistry , allosteric regulation , plasma protein binding , ligand (biochemistry) , conformational change , protein structure , nucleotide , biochemistry , biology , enzyme , receptor , heat shock protein , gene
Hsp90 is one of the most abundant chaperone proteins in the cytosol. In an ATP‐dependent manner it plays an essential role in the folding and activation of a range of client proteins involved in signal transduction and cell cycle regulation. We used NMR shift perturbation experiments to obtain information on the structural implications of the binding of AMP‐PNP (adenylyl‐imidodiphosphate—a non‐hydrolysable ATP analogue), ADP and the inhibitors radicicol and geldanamycin. Analysis of 1 H, 15 N correlation spectra showed a specific pattern of chemical shift perturbations at N210 (ATP binding domain of Hsp90, residues 1–210) upon ligand binding. This can be interpreted qualitatively either as a consequence of direct ligand interactions or of ligand‐induced conformational changes within the protein. All ligands show specific interactions in the binding site, which is known from the crystal structure of the N‐terminal domain of Hsp90. For AMP‐PNP and ADP, additional shift perturbations of residues outside the binding pocket were observed and can be regarded as a result of conformational rearrangement upon binding. According to the crystal structures, these regions are the first α ‐ helix and the “ATP‐lid” ranging from amino acids 85 to 110. The N‐terminal domain is therefore not a passive nucleotide‐binding site, as suggested by X‐ray crystallography, but responds to the binding of ATP in a dynamic way with specific structural changes required for the progression of the ATPase cycle.